Literature DB >> 7489365

Tamoxifen elevates transforming growth factor-beta and suppresses diet-induced formation of lipid lesions in mouse aorta.

D J Grainger1, C M Witchell, J C Metcalfe.   

Abstract

When C57B16 male mice are fed a high-fat diet, they develop significant fatty streak lesions in the aorta. Addition of tamoxifen (TMX) to a high-fat diet, equivalent to a dose of approximately 1 mg TMX per kg body weight per day, suppressed the diet-induced increase in the area of lipid staining in the aortic sinus of the mice by 88% and in the average number of lesions by 86%. The TMX-treated mice had 11% +/- 5% less total plasma cholesterol, with most of the reduction in the high density lipoprotein fraction, whereas plasma triglycerides were significantly elevated, and circulating concentrations of 17 beta-estradiol and testosterone were unaffected. Both circulating and aortic concentrations of active and latent transforming growth factor-beta (TGF-beta) were substantially elevated by TMX. The inhibition of lesion formation may be due, at least in part, to cardiovascular protection by TGF-beta.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7489365     DOI: 10.1038/nm1095-1067

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  17 in total

1.  Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)γ-DEPENDENT MECHANISM.

Authors:  Miao Yu; Meixiu Jiang; Yuanli Chen; Shuang Zhang; Wenwen Zhang; Xiaoxiao Yang; Xiaoju Li; Yan Li; Shengzhong Duan; Jihong Han; Yajun Duan
Journal:  J Biol Chem       Date:  2016-06-29       Impact factor: 5.157

2.  Differential regulation of extracellular signal-regulated protein kinases (ERKs) 1 and 2 by cAMP and dissociation of ERK inhibition from anti-mitogenic effects in rabbit vascular smooth muscle cells.

Authors:  R Cospedal; M Lobo; I Zachary
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

Review 3.  The latent transforming growth factor beta binding protein (LTBP) family.

Authors:  R Oklü; R Hesketh
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

4.  Apoptosis and tumorigenesis in human cholangiocarcinoma cells. Involvement of Fas/APO-1 (CD95) and calmodulin.

Authors:  G Pan; S M Vickers; A Pickens; J O Phillips; W Ying; J A Thompson; G P Siegal; J M McDonald
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

5.  Gender-based differences in bleomycin-induced pulmonary fibrosis.

Authors:  Mehrnaz Gharaee-Kermani; Kazuo Hatano; Yasuhiro Nozaki; Sem H Phan
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

6.  Essential role of bone marrow fibroblast growth factor-2 in the effect of estradiol on reendothelialization and endothelial progenitor cell mobilization.

Authors:  Vincent Fontaine; Cédric Filipe; Nikos Werner; Pierre Gourdy; Audrey Billon; Barbara Garmy-Susini; Laurent Brouchet; Francis Bayard; Hervé Prats; Thomas Doetschman; Georg Nickenig; Jean-François Arnal
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

7.  Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice.

Authors:  P A Bourassa; P M Milos; B J Gaynor; J L Breslow; R J Aiello
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

8.  Disruption of TGF-beta signaling in T cells accelerates atherosclerosis.

Authors:  Anna-Karin L Robertson; Mats Rudling; Xinghua Zhou; Leonid Gorelik; Richard A Flavell; Göran K Hansson
Journal:  J Clin Invest       Date:  2003-10-20       Impact factor: 14.808

9.  Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia.

Authors:  A H Schulick; A J Taylor; W Zuo; C B Qiu; G Dong; R N Woodward; R Agah; A B Roberts; R Virmani; D A Dichek
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

10.  Treatment with selective estrogen receptor modulators regulates myelin specific T-cells and suppresses experimental autoimmune encephalomyelitis.

Authors:  Bruce F Bebo; Babak Dehghani; Scott Foster; Astrid Kurniawan; Francisco J Lopez; Larry S Sherman
Journal:  Glia       Date:  2009-05       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.